≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_MYELODYSP_SYNDR_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D46
  • Cause of death: ICD-10 — D46
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 9980|998[2-7]|9989
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

1018

4. Check minimum number of events

None

1018

5. Include endpoints

None

1018

6. Filter based on genotype QC (FinnGen only)

1018

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 1018 375 643
Unadjusted period prevalence (%) 0.23 0.13 0.28
Median age at first event (years) 73.63 71.28 75.00

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
274
Matched controls
2739
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
1131.2
198.7
171
*
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
+∞
193.4
162
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
181.7
149.1
146
17
XW000
NOMESCO Finland
Bone marrow biopsy
115.5
134.0
139
24
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
+∞
122.3
108
*
WW500
NOMESCO Finland
Blood transfusion
86.1
104.0
113
22
D64.9
ICD-10 Finland
Anaemia, unspecified
15.8
83.1
160
223
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
860.8
70.3
66
*
B03XA02
ATC
darbepoetin alfa; parenteral
46.6
48.7
59
16
A04AA01
ATC
ondansetron; systemic, rectal
46.6
48.7
59
16
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
+∞
45.1
42
*
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
503.6
44.6
43
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
74.1
43.9
49
8
L03AA02
ATC
filgrastim; parenteral
169.2
42.1
43
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
41.7
39
*
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
+∞
39.5
37
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
37.3
35
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
84.9
33.8
37
5
B03XA01
ATC
erythropoietin; parenteral
42.5
30.2
37
10
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
298.8
27.2
27
*
Z51.5
ICD-10 Finland
Palliative care
14.7
26.5
45
36
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
25.4
24
*
127
Kela drug reimbursment
Transplant complication
77.5
25.3
28
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
62.0
24.5
28
5
ZX112
NOMESCO Finland
Subcutaneous
62.0
24.5
28
5
306
Kela drug reimbursment
Erythropoietin and darbepoetin
91.4
23.1
25
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.3
22.8
78
191
L04AD01
ATC
ciclosporin; systemic
47.7
21.8
26
6
C61
ICD-10 Finland
Malignant neoplasm of prostate
83.5
21.0
23
*
ZX120
NOMESCO Finland
Intravenous
7.3
20.7
52
85
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
19.0
18
*
JN4BD
NOMESCO Finland
Extensive body CT
8.7
18.7
41
54
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
13.8
18.7
32
26
A05AA02
ATC
ursodeoxycholic acid; oral
29.0
18.1
24
9
R50.9
ICD-10 Finland
Fever, unspecified
4.7
18.1
68
181
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
17.9
17
*
116
Kela drug reimbursment
Prostate cancer
+∞
17.9
17
*
9982/3-C42.1
ICD-O-3
Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia of bone marrow
+∞
16.8
16
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
15.8
15
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
84.8
14.7
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
14.7
14
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
14.7
14
*
B82
ICPC
Anaemia other/unspecified
11.0
14.3
27
27
H02AB06
ATC
prednisolone; systemic
2.7
13.7
147
826
1BC07
NOMESCO Finland
NA
+∞
13.7
13
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
147.0
13.6
14
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.5
13.3
27
31
N02AA05
ATC
oxycodone; systemic
3.7
13.2
64
211
SPAT1088
SPAT
Blood transfusion
52.6
13.0
15
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
73.4
12.7
14
*
WW200
NOMESCO Finland
Immunization
14.1
12.7
21
16
9985/3-C42.1
ICD-O-3
Myelodysplastic syndrome with multilineage dysplasia of bone marrow
+∞
12.6
12
*
9980/3-C42.1
ICD-O-3
Myelodysplastic syndrome with single lineage dysplasia of bone marrow
+∞
12.6
12
*
M04AA01
ATC
allopurinol; systemic
3.1
11.8
75
300
J02AC03
ATC
voriconazole; systemic
67.9
11.7
13
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.2
11.6
31
55
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
11.5
11
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
11.5
11
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
11.5
11
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
11.4
53
168
L04AA06
ATC
mycophenolic acid; systemic
21.1
11.3
16
8
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.7
11.2
32
62
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
9.5
11.0
22
25
J01MA12
ATC
levofloxacin; systemic
2.9
10.9
76
319
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
10.9
120
659
A03FA01
ATC
metoclopramide; systemic, rectal
3.7
10.7
48
147
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
10.7
67
264
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.0
10.6
29
53
D46.4
ICD-10 Finland
Refractory anaemia, unspecified
114.2
10.5
11
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
10.5
10
*
J05AB11
ATC
valaciclovir; oral
3.8
10.5
45
133
A41.9
ICD-10 Finland
Sepsis, unspecified
6.1
10.4
28
50
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
10.1
106
563
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
10.1
132
782
JN4AD
NOMESCO Finland
Body CT examination
7.6
9.7
22
31
B73
ICPC
Leukaemia
+∞
9.4
9
*
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
+∞
9.4
9
*
V03AC03
ATC
deferasirox; oral
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.4
9
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
9.0
98
524
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
8.9
118
693
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
8.4
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.4
8
*
D46
ICD-10 Finland
Myelodysplastic syndromes
+∞
8.4
8
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
34.5
8.1
10
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
22.8
8.1
11
5
A02BC02
ATC
pantoprazole; systemic
2.1
8.0
167
1172
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
7.8
65
298
UJF30
NOMESCO Finland
Ileoscopy through colon
4.0
7.8
30
81
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
82.2
7.5
8
*
J01MA02
ATC
ciprofloxacin; systemic
2.1
7.4
121
759
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
+∞
7.3
7
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
7.3
7
*
130
Kela drug reimbursment
Malignant tumour
+∞
7.3
7
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
+∞
7.3
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.3
7
*
J01MA14
ATC
moxifloxacin; systemic
3.5
7.2
33
103
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
7.2
29
82
TGC00
NOMESCO Finland
Bronchial lavation
7.3
7.1
16
23
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.4
6.7
23
56
H02AB04
ATC
methylprednisolone; systemic
2.6
6.5
48
206
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
6.5
32
106
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.5
6.4
13
16
H02AB02
ATC
dexamethasone; systemic
11.4
6.4
11
10
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.3
6.3
18
36
C90.0
ICD-10 Finland
Multiple myeloma
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
B74
ICPC
Malignant neoplasm blood other
+∞
6.3
6
*
WW409
NOMESCO Finland
Other aferesis
+∞
6.3
6
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
6.3
6
*
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
6.3
6
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
H02AB07
ATC
prednisone; oral
2.5
6.1
48
214

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
359
55
100.29
307.65
1.5
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
358
101
54.13
307.65
3.0
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
581
1054
11.51
307.65
7.4
1.9
%
2.0
1.8
2.94
537
916
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
316
131
34.53
307.65
1.4
1.1
u/l
136.9
20.7
12.83
281
117
(3023520) Reticulocytes [#/volume] in Blood
512
774
12.30
307.65
7.1
2.1
e9/l
70.1
67.5
0.30
426
614
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
576
790
15.49
307.65
12.6
2.5
u/l
257.9
240.3
2.13
550
725
(3045142) Bone marrow Pathology biopsy report
231
49
60.69
307.65
1.8
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
262
190
18.22
295.94
2.7
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
344
404
12.35
287.35
2.4
1.6
g/l
1.1
1.5
8.28
292
341
(3017181) Myelocytes/100 leukocytes in Blood
350
527
9.60
238.18
13.9
3.5
%
1.5
0.8
3.38
252
122
(3004809) Band form neutrophils/100 leukocytes in Blood
176
87
24.25
236.72
10.3
3.2
%
1.3
1.5
0.10
139
59
(3048879) Bone marrow aspiration report
104
17
68.02
189.39
3.1
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
148
83
20.69
187.41
11.6
4.3
iu/ml
627.7
884.3
—
28
10
(4035726)
187
176
12.79
177.82
1.7
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
284
476
7.89
172.05
14.1
3.5
%
0.8
0.5
0.91
169
89
(3021440) Promyelocytes/100 leukocytes in Blood
289
502
7.64
169.21
14.3
3.6
%
0.2
0.0
1.89
225
113
(3020630) Protein [Mass/volume] in Serum or Plasma
332
693
6.63
161.79
2.8
1.6
g/l
66.7
66.5
0.12
311
606
(3017354) Segmented neutrophils/100 leukocytes in Blood
124
67
20.94
159.18
9.8
3.0
%
49.3
55.8
0.98
82
41
(3008757) Leukocyte morphology finding [Identifier] in Blood
119
68
19.68
148.73
12.2
3.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
117
65
20.21
148.13
3.8
2.4
u/ml
298.6
367.4
—
13
7
(3025159) Blasts/100 leukocytes in Blood
261
476
7.03
144.40
14.5
3.6
%
0.8
0.9
0.05
182
95
(3005719) IgG [Mass/volume] in Serum or Plasma
241
423
7.15
137.99
3.3
2.1
g/l
11.1
11.0
0.11
219
384
(3022948) Iron [Moles/volume] in Serum or Plasma
427
1262
5.11
137.99
3.1
2.4
umol/l
17.3
12.4
16.92
409
1139
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
389
1072
5.25
136.70
3.2
2.5
%
36.5
22.4
21.51
335
895
(3004789) Transferrin [Mass/volume] in Serum or Plasma
399
1142
5.10
133.51
3.1
2.4
g/l
2.0
2.2
12.82
386
1046
(3004588) Protein electrophoresis panel - Serum or Plasma
282
605
6.06
131.28
2.7
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
108
72
16.66
124.70
1.1
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
568
2289
4.35
118.42
23.1
4.8
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
171
261
7.67
110.39
2.5
1.4
ratio
5.1
1.3
1.03
13
22
(3034860) Kappa light chains.free [Mass/volume] in Serum
172
268
7.52
108.93
2.5
1.4
mg/l
48.9
50.8
0.11
150
212
(3028026) IgM [Mass/volume] in Serum or Plasma
194
345
6.71
108.38
2.1
1.3
g/l
1.5
1.1
0.75
175
313
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
99
73
14.91
107.97
1.5
1.3
u/ml
110.4
112.7
—
29
6
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
171
268
7.47
107.68
2.5
1.4
mg/l
50.8
37.2
0.38
147
214
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
134
157
9.68
107.67
3.3
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
653
3095
4.10
103.86
21.9
5.0
%
0.8
0.6
3.27
629
2831
(3019069) Monocytes/100 leukocytes in Blood
665
3208
4.09
102.65
25.0
5.3
%
11.9
8.9
17.61
639
2937
(3021879) Hepatitis B virus core Ab [Presence] in Serum
169
276
7.14
102.25
1.4
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
126
146
9.71
101.97
3.7
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
661
3192
4.05
101.49
22.9
5.0
%
2.3
3.0
8.16
635
2909
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
76
37
22.12
101.37
1.4
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
666
3261
4.01
99.50
24.0
5.1
%
30.5
25.7
13.96
641
2969
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
76
39
20.98
99.10
2.8
2.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
98
85
12.65
96.87
1.3
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
138
194
8.07
95.35
2.7
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
511
2146
3.77
95.20
3.2
2.2
mg/l
3.2
3.0
0.78
451
1797
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
70
33
22.70
94.52
1.6
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
70
33
22.70
94.52
1.6
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
105
107
10.83
93.17
3.6
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
95
86
12.08
91.28
1.4
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
609
2940
3.67
89.97
5.5
2.8
ug/l
464.5
138.9
28.99
577
2657
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
91
80
12.39
89.07
1.3
1.1
u/ml
310.5
278.1
0.28
57
40
(3044640) Blood type and Crossmatch panel - Blood
494
2101
3.63
88.85
15.9
2.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
644
3239
3.69
88.82
21.0
5.0
%
50.1
58.9
35.97
615
2972
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
61
24
26.97
88.15
10.0
2.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
210
483
5.22
88.14
1.5
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
103
114
9.94
85.99
1.3
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
674
3544
3.67
85.46
20.9
4.8
e9/l
0.1
0.2
20.18
614
3049
(3026493) Urate [Moles/volume] in Serum or Plasma
471
1991
3.54
84.64
5.9
2.5
umol/l
1346.4
8695.2
4.81
437
1667
(3011412) CD3 cells [#/volume] in Blood
62
30
21.94
82.69
6.0
1.9
e9/l
0.8
1.0
0.30
33
17
(3001604) Monocytes [#/volume] in Blood
653
3415
3.54
82.45
18.3
4.7
e9/l
0.7
0.6
0.74
598
2892
(3003458) Phosphate [Moles/volume] in Serum or Plasma
312
1027
3.94
81.65
7.5
4.6
mmol/l
1.1
1.0
3.79
293
928
(3006315) Basophils [#/volume] in Blood
654
3437
3.52
81.63
18.4
4.8
e9/l
0.0
0.0
1.29
599
2917
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
671
3583
3.56
81.59
16.7
3.6
umol/l
13.9
12.6
1.80
649
3326
(3013650) Neutrophils [#/volume] in Blood by Automated count
694
3801
3.59
80.62
33.3
5.5
e9/l
3.5
4.5
3.82
642
3262
(3019198) Lymphocytes [#/volume] in Blood
656
3493
3.47
79.30
19.5
4.9
e9/l
1.5
1.8
12.87
611
3006
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
216
561
4.62
77.63
1.5
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
53
20
27.90
77.58
6.7
1.8
e6/l
440.8
919.7
—
27
10
(46235355) HIV 1 and 2 tests - Meaningful Use set
237
672
4.29
75.84
1.5
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
47
13
37.86
75.54
1.1
1.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
165
351
5.42
75.18
2.3
1.4
g/l
6.5
7.5
8.89
110
252
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
165
351
5.42
75.18
2.3
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
165
351
5.42
75.18
2.3
1.4
g/l
3.7
3.9
0.46
109
246
(3023368) Bacteria identified in Blood by Culture
500
2331
3.25
74.19
8.9
4.0
—
—
—
0
0
(3024471) HLA-A [Type]
44
10
45.94
74.18
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
44
10
45.94
74.18
1.7
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
598
3147
3.18
71.00
24.0
3.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
303
1072
3.60
69.98
5.9
2.3
mmol/l
0.8
0.8
2.79
283
977
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
102
144
7.76
69.74
3.2
2.5
%
87.2
86.1
0.17
102
136
(40760892) CBC W Ordered Manual Differential panel - Blood
343
1319
3.41
69.36
18.1
3.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
438
1965
3.16
68.14
2.2
1.8
nmol/l
1322.9
1169.7
2.25
351
1472
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
385
1610
3.24
67.47
14.6
2.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
149
329
5.13
64.69
2.1
1.4
g/l
12.0
10.7
1.51
127
273
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
57
39
15.42
64.33
1.6
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
46
20
24.04
63.81
5.6
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
46
20
24.04
63.81
5.6
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
46
20
24.04
63.81
5.6
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
69
66
11.14
63.61
4.6
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
326
5.10
63.46
2.4
1.4
g/l
3.2
3.1
0.39
109
250
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
51
29
18.46
63.14
5.2
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
51
29
18.46
63.14
5.2
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
51
29
18.46
63.14
5.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
51
29
18.46
63.14
5.2
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
65
59
11.70
62.03
4.5
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
65
59
11.70
62.03
4.5
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
65
59
11.70
62.03
4.5
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
71
74
10.24
61.64
4.5
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
85
113
8.12
61.06
1.8
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
346
1437
3.13
60.28
3.5
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
100
164
6.65
59.42
1.5
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
192
560
3.99
58.10
2.6
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
314
1258
3.16
57.89
3.2
1.8
s
30.1
30.1
0.06
303
1215
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
62
6
109.93
57.51
1.7
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
649
3849
2.89
57.35
12.8
5.4
mmol/l
1.2
1.2
5.86
559
3231
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
45
24
19.57
57.30
2.8
2.0
%
13.0
15.9
0.34
19
11
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
217
706
3.64
55.84
8.9
2.5
umol/l
8.2
9.4
0.50
206
600
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
48
32
15.69
54.83
3.2
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
128
288
4.94
54.05
2.6
1.4
g/l
1.3
0.5
1.09
114
243
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
42
22
19.87
53.86
2.2
2.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
91
8.31
52.48
1.6
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
117
251
5.14
52.20
2.5
1.4
g/l
0.3
0.0
0.49
111
230
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
70
91
8.19
51.12
1.8
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
426
2131
2.72
50.90
2.2
1.6
nmol/l
20.5
20.0
0.22
394
1791
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
64
75
9.04
50.80
1.2
1.0
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
69
89
8.24
50.71
7.8
6.5
mg/l
12.1
12.4
0.21
62
82
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
62
70
9.37
50.63
1.7
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
137
346
4.42
50.01
2.4
1.6
ug/l
7.0
2.1
0.65
115
298
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
590
3490
2.64
49.68
10.7
5.1
mmol/l
1.2
1.2
4.68
553
3072
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
116
259
4.93
49.32
2.9
3.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
554
3240
2.56
46.83
9.8
3.7
g/l
33.6
34.7
3.49
521
2955
(3020779) Urea [Moles/volume] in Serum or Plasma
201
692
3.37
46.78
8.5
5.4
mmol/l
11.1
11.7
0.41
191
641
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
70
102
7.30
46.27
1.9
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
268
1106
2.93
45.57
1.7
1.3
g/l
2.8
2.8
0.03
200
617
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
65
90
7.65
44.93
1.9
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
58
70
8.73
44.93
3.0
2.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
115
277
4.55
44.45
2.1
1.4
g/l
37.3
36.7
0.36
100
227
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
104
235
4.82
43.47
2.2
1.4
g/l
0.0
0.0
0.50
98
214
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
103
231
4.85
43.44
2.2
1.4
g/l
0.0
0.0
0.00
98
213
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
45
40
11.72
43.36
1.5
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
29
10
29.82
43.34
2.3
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
74
123
6.41
43.20
4.8
2.7
%
179.8
199.7
1.04
74
115
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
246
1008
2.90
42.04
2.6
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
37
26
14.73
40.95
2.9
1.9
%
41.9
45.9
0.21
12
14
(3008536) Aspergillus sp Ab [Presence] in Serum
48
9
55.86
40.83
4.9
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
576
3577
2.41
40.64
3.0
2.1
pmol/l
90.4
91.8
0.29
399
1859
(3018418) pH of Serum or Plasma
414
2225
2.45
40.48
8.3
3.1
ph
7.4
7.4
0.63
82
381
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
242
1012
2.83
39.58
2.7
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
27
10
27.71
39.36
10.6
1.6
—
—
—
0
0
(44790049)
56
76
7.74
39.34
2.0
1.3
—
—
—
0
0
(44790047)
56
76
7.74
39.34
2.0
1.3
—
—
—
0
0
(44790048)
56
76
7.74
39.34
2.0
1.3
—
—
—
0
0
(44806118)
56
76
7.74
39.34
2.0
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
106
266
4.33
38.76
1.9
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
75
148
5.39
36.56
1.4
2.1
mg/l
15.3
12.3
0.74
62
135
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
26
11
24.23
36.12
1.2
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
26
11
24.23
36.12
2.9
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
55
81
7.12
35.93
1.3
1.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
244
1074
2.67
35.77
2.3
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
42
47
9.28
34.41
2.5
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
191
771
2.82
32.91
1.5
1.3
titre
584.1
581.0
0.01
58
181
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
29
20
14.90
32.32
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
69
141
5.18
32.31
1.9
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
23
10
23.51
31.54
1.2
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
309
1599
2.34
31.45
24.5
4.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
28
20
14.37
30.59
1.1
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
33
31
10.97
30.56
2.5
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
33
31
10.97
30.56
2.5
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
25
15
17.06
29.86
1.1
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
124
416
3.26
29.46
2.6
1.4
ug/l
13.7
3.8
0.49
95
309
(3014148) Varicella zoster virus Ab [Titer] in Serum
36
41
9.07
29.06
1.1
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
280
1447
2.29
28.14
2.3
1.6
mg/l
1.8
1.3
1.84
242
1124
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
39
52
7.76
27.74
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
34
39
8.98
27.29
1.1
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
30
29
10.63
27.22
1.2
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
24
16
15.34
27.15
1.2
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
36
45
8.26
27.01
2.6
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
36
45
8.26
27.01
2.5
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
60
127
4.96
26.95
1.1
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
20
10
20.38
25.84
1.3
2.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
438
2775
2.02
25.37
4.9
3.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
723
5494
2.09
24.63
21.7
5.1
u/l
81.6
78.0
0.92
698
5005
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
344
2015
2.07
24.62
4.6
2.5
u/l
37.2
34.8
0.22
324
1904
(3017732) Neutrophils [#/volume] in Blood
121
444
2.96
24.53
4.9
3.0
e9/l
3.5
4.2
0.83
81
307
(3033658) Prothrombin time (PT) actual/Normal
299
1667
2.12
24.37
8.3
3.6
%
76.3
81.0
2.69
292
1617
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
24
11.09
24.29
1.2
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
19
10
19.34
23.97
1.4
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
21
14
15.29
23.70
1.2
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
103
352
3.14
23.61
4.8
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
68
179
4.00
23.18
1.4
1.6
iu/ml
0.2
0.2
0.04
22
45
(3003694) ABO and Rh group [Type] in Blood
292
1641
2.09
23.13
2.0
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
187
881
2.38
22.84
1.9
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
44
83
5.50
22.47
1.1
1.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
371
2293
1.97
22.41
2.9
2.2
u/l
53.3
56.9
1.27
344
2093
(3013826) Glucose [Moles/volume] in Serum or Plasma
622
4565
1.93
22.32
8.5
4.3
mmol/l
7.0
7.0
0.20
602
4266
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
29
36
8.26
21.84
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
331
1999
1.97
21.14
2.5
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
136
573
2.59
21.05
2.2
2.0
g/l
0.2
0.2
1.02
115
505
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
34
53
6.60
21.02
1.9
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
42
81
5.37
20.94
4.8
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
41
79
5.37
20.46
4.8
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
60
158
3.97
20.43
3.7
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
78
248
3.32
20.09
1.4
2.0
u/l
32.0
40.8
3.03
67
203
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
43
7.16
20.01
1.8
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
41
81
5.23
19.90
4.9
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
41
81
5.23
19.90
4.9
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
128
544
2.55
19.41
2.6
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
42
87
4.99
19.33
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
38
72
5.44
19.31
1.9
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
40
80
5.16
19.16
5.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
40
81
5.10
18.89
5.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
45
101
4.62
18.84
9.0
2.8
%
54.4
60.2
1.32
45
101
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
90
324
2.95
18.79
2.8
1.6
—
—
—
0
0
(3019225) pH of Specimen
164
799
2.25
18.27
8.3
3.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
161
780
2.26
18.18
2.8
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
479
3380
1.79
17.99
9.6
12.3
inr
1.3
1.4
2.58
129
932
(3021589) Normoblasts [#/volume] in Blood
441
3039
1.80
17.93
33.6
8.5
e9/l
0.1
0.0
0.65
387
2451
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
120
516
2.50
17.71
1.6
1.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
23
29
8.09
17.07
1.2
1.0
mg/l
57.5
64.4
0.20
17
18
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
24
32
7.66
17.02
2.0
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
24
33
7.42
16.58
2.0
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
328
2110
1.82
16.47
4.4
3.1
e6/l
0.7
0.5
0.50
262
1624
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
22
28
8.01
16.20
1.2
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
416
2881
1.75
16.16
3.6
3.2
ng/l
2185.0
1888.7
0.69
380
2502
(3002582) Erythrocytes [#/volume] in Urine
352
2335
1.78
15.81
4.5
3.1
e6/l
174.6
95.3
0.38
287
1823
(4212803)
20
6
33.95
15.77
1.2
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
174
921
2.07
15.56
1.4
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
19
5
38.69
15.42
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
62
203
3.19
15.22
2.1
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
14
10
14.18
15.06
1.4
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
19
22
8.78
15.05
1.3
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
40
98
4.21
15.02
1.2
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
306
1983
1.78
14.69
1.8
1.8
pmol/l
50612749.0
12825696.6
0.34
245
1614
(3028308) Erythrocytes [#/volume] in Pleural fluid
38
92
4.25
14.49
1.5
1.5
e6/l
238811.2
95475.5
0.33
25
56
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
114
524
2.32
14.45
6.3
3.6
mmol/l
1.5
1.9
0.33
87
376
(3023199) Leukocytes [#/volume] in Pleural fluid
40
101
4.08
14.44
1.5
1.5
e6/l
1039.2
1742.1
0.99
33
71
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
52
158
3.41
14.39
3.6
3.5
mg/l
1.5
1.7
0.83
46
135
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
19
7
27.61
14.30
1.7
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
385
2677
1.70
14.30
5.2
3.6
e6/l
58.6
116.2
1.98
302
1949
(3014111) Lactate [Moles/volume] in Serum or Plasma
139
700
2.14
14.10
5.9
5.5
mmol/l
1.6
1.5
0.16
133
665
(3009343) pH of Capillary blood
116
543
2.28
14.09
6.3
3.7
ph
7.4
7.4
1.78
14
63
(36304419) Bacteria [Presence] in Urine
309
2029
1.75
14.07
4.4
3.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
83
335
2.61
13.92
7.3
4.1
mmol/l
24.8
24.7
0.06
76
301
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
29
58
5.12
13.90
1.1
1.1
u/l
49.1
54.5
0.25
24
36
(3016502) Oxygen saturation in Arterial blood
162
870
2.03
13.84
6.3
6.0
%
94.6
94.8
0.16
156
832
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
117
555
2.25
13.76
6.3
3.6
kpa
5.1
5.2
0.17
105
504
(3015171) Extractable nuclear Ab [Units/volume] in Serum
60
205
3.05
13.72
1.4
1.2
u/ml
3.0
0.3
—
9
19
(3031040) Bacteria [#/volume] in Urine by Automated count
630
5014
1.67
13.71
6.6
4.7
e6/l
13.0
3160.2
—
8
96
(3012441) Differential panel - Pleural fluid
36
88
4.20
13.56
1.5
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
204
1197
1.88
13.41
3.9
3.0
e6/l
1.6
2.2
0.87
114
670
(3047189) Immunofixation for 24 hour Urine
21
32
6.68
13.23
1.4
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
214
1282
1.85
13.16
3.7
2.7
e6/l
2.1
1.3
0.77
127
751
(3013707) Erythrocyte sedimentation rate by Westergren method
663
5377
1.67
13.13
6.8
4.1
mm/h
24.2
13.8
22.72
619
4877
(40761535) Cells panel - Urine sediment
137
707
2.08
13.01
4.6
3.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
72
281
2.68
12.91
3.0
2.7
u/ml
0.3
0.3
1.33
37
174
(3002173) Hemoglobin [Mass/volume] in Arterial blood
146
775
2.03
12.84
6.6
6.4
g/l
103.6
121.1
15.64
141
750
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
16
5
32.47
12.59
1.2
4.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
354
2472
1.66
12.57
3.6
2.1
mmol/l
2.3
2.3
4.01
302
2007
(3043410) Blood group antigens tested for on Red Blood Cells
16
19
8.54
12.39
8.5
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
170
972
1.90
12.01
6.2
5.9
kpa
4.9
5.1
0.75
164
920
(3027801) Oxygen [Partial pressure] in Arterial blood
170
972
1.90
12.01
6.2
5.8
kpa
11.4
11.2
0.15
164
917
(3036481) Cortisol [Moles/volume] in Serum or Plasma
119
600
2.11
11.98
2.0
1.7
nmol/l
341.7
363.3
0.58
114
535
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
46
147
3.23
11.78
1.7
1.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
46
151
3.14
11.28
2.9
2.4
umol/l
33.8
35.2
0.12
32
131
(40768806) Pleura Pathology biopsy report
31
78
4.07
11.27
1.6
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
21
38
5.62
11.20
1.5
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
355
2539
1.61
11.17
4.3
3.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
70
290
2.52
11.14
1.2
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
167
974
1.85
11.04
6.3
5.8
mmol/l
1.2
1.3
0.12
129
737
(3002256) Pathology report gross observation
97
467
2.19
10.97
1.6
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
17
8.34
10.63
1.7
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
249
1646
1.68
10.63
3.4
2.4
e6/l
5.6
5.2
0.20
225
1436
(3002032) Base excess in Venous blood by calculation
149
850
1.88
10.54
4.6
3.2
mmol/l
1.6
2.0
0.61
119
664
(3022313) Gas panel - Capillary blood
86
401
2.25
10.52
6.7
3.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
31
83
3.82
10.37
1.5
1.7
g/l
1.0
1.0
0.02
23
64
(3017704) Immunofixation for Urine
24
53
4.61
10.28
1.3
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
33
95
3.56
9.96
2.6
2.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
92
451
2.14
9.95
3.1
2.4
—
—
—
0
0
(3012544) pH of Venous blood
150
881
1.82
9.64
4.6
3.3
—
7.4
—
0
6
(4062490)
24
56
4.37
9.62
1.2
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
18
33
5.53
9.47
1.5
1.4
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
9
0
+∞
9.39
1.0
0.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
23
53
4.42
9.36
1.2
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
13
6
21.92
9.36
1.1
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
621
5170
1.52
9.21
6.4
4.3
—
—
—
0
0
(3026782) Osmolality of Urine
233
1565
1.63
9.20
3.7
2.6
mosm/kgh2o
525.5
550.8
1.24
208
1310
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
105
561
1.97
9.00
2.4
2.1
u/l
48.0
30.7
0.58
89
446
(3045788) Cell count panel - Pleural fluid
29
82
3.61
9.00
1.6
1.6
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
13
18
7.30
8.86
1.2
1.2
ug/l
1.6
1.3
—
7
9
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
84
417
2.11
8.80
7.7
8.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
388
2952
1.51
8.77
2.6
2.2
nmol/l
79.8
78.8
0.28
339
2526
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
427
3326
1.49
8.55
3.1
2.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
62
3.94
8.45
1.1
1.2
u/ml
1.5
1.6
—
8
23
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
109
609
1.88
8.18
4.1
2.8
mmol/l
1.2
1.2
3.34
104
508
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
51
212
2.48
8.11
2.1
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
71
341
2.16
8.10
1.3
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
22
55
4.07
8.10
1.2
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
43
166
2.66
7.94
1.4
1.2
u/ml
1.7
3.3
—
7
16
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
499
4047
1.46
7.93
4.0
3.0
u/l
65.5
49.6
2.23
455
3648
(3028192) IgG subclass 2 [Mass/volume] in Serum
22
56
3.99
7.91
1.2
1.2
g/l
3.3
2.6
0.72
15
42
(3027135) IgG subclass 1 [Mass/volume] in Serum
22
56
3.99
7.91
1.2
1.2
g/l
7.1
7.7
0.29
15
42
(3024139) IgG subclass 3 [Mass/volume] in Serum
22
56
3.99
7.91
1.2
1.2
g/l
0.6
0.4
1.00
15
42
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
427
3363
1.46
7.90
5.5
4.3
ng/l
77.3
77.5
0.00
351
2591
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
242
1697
1.56
7.84
4.6
4.2
ng/l
244.2
449.5
1.20
208
1480
(3008152) Bicarbonate [Moles/volume] in Arterial blood
104
583
1.87
7.73
5.9
6.2
mmol/l
24.4
24.4
0.00
97
545
(3000991) Gas panel - Venous blood
115
666
1.82
7.70
7.9
6.6
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
11
6
18.51
7.61
1.1
1.2
%
100.9
93.0
—
11
6
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
99
549
1.89
7.60
1.5
1.6
%
1.8
1.6
0.59
70
451
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
43
170
2.60
7.59
1.4
1.2
u/ml
3.8
7.4
—
10
26
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
63
3.71
7.49
1.1
1.2
u/ml
3.5
7.1
0.55
13
31
(3035350) Ketones [Presence] in Urine by Test strip
452
3630
1.44
7.40
4.9
3.8
estimate
0.0
0.0
0.00
87
633
(3003327) Ova and parasites identified in Stool by Light microscopy
43
173
2.55
7.33
2.3
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
110
638
1.81
7.33
3.5
3.7
ng/l
82.9
94.5
0.83
93
548
(3019060) Gas panel - Arterial blood
104
598
1.82
7.13
4.2
4.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
76
3.35
7.00
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
30
105
2.91
6.67
1.3
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
451
3670
1.41
6.63
5.0
3.8
estimate
0.0
0.0
0.00
82
619
(3052851) Hemolysis interference index of Serum or Plasma
49
222
2.27
6.48
4.4
3.5
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
6
0
+∞
6.25
1.3
0.0
%
7.0
—
—
6
0
(3049242) von Willebrand panel - Platelet poor plasma
6
0
+∞
6.25
1.5
0.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
6
0
+∞
6.25
1.0
0.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
17
43
4.00
6.18
1.2
1.7
umol/l
12.2
15.2
0.87
17
36
(3021601) Nitrite [Presence] in Urine by Test strip
442
3618
1.39
6.13
6.6
5.1
estimate
0.0
0.0
0.00
86
619
(3007930) Methemoglobin/Hemoglobin.total in Blood
69
367
1.94
6.03
5.7
4.0
%
0.9
0.9
0.40
64
350
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
23
74
3.16
5.92
1.2
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
73
400
1.89
5.85
4.0
3.7
mmol/l
24.2
24.2
0.01
63
349
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
21
65
3.28
5.75
1.3
1.2
u/ml
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
38
163
2.38
5.71
1.2
1.1
titre
101.7
75.5
—
6
11
(3020393) Adenovirus Ag [Presence] in Stool
8
5
16.12
5.41
1.4
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
34
4.16
5.37
1.6
1.4
u/l
5.4
10.3
—
9
15
(3015736) pH of Urine
357
2869
1.38
5.35
4.6
3.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
37
162
2.33
5.33
4.1
3.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
68
376
1.87
5.31
5.8
3.9
%
1.8
1.7
0.22
63
359
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
325
2580
1.38
5.23
2.5
2.2
u/l
357.0
273.6
0.14
304
2408
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
0
+∞
5.21
2.2
0.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
0
+∞
5.21
2.2
0.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
19
59
3.26
5.19
1.3
1.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
76
439
1.79
5.17
6.4
3.4
%
47.2
47.1
0.01
76
432
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
46
224
2.10
5.15
1.4
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
6
13.42
5.08
1.3
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
186
1349
1.46
4.95
22.3
31.3
inr
1.4
1.5
0.54
27
185
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
147
1021
1.51
4.84
1.3
1.3
iu/ml
32.3
38.6
0.22
43
319
(3023419) Bacteria identified in Sputum by Culture
28
114
2.50
4.74
2.2
2.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
38
178
2.18
4.71
6.2
4.2
mmol/l
2.3
2.8
0.39
26
121
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
60
333
1.85
4.66
2.2
2.1
ug/l
747.4
542.0
0.25
53
308
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
131
1857
0.66
4.64
1.9
1.6
mmol/l
1.4
1.3
0.59
115
1530
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
5
14.08
4.58
1.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
21
4.80
4.54
1.1
1.0
miu/ml
1501.8
1760.3
—
10
21
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
39
3.63
4.49
1.6
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
25
99
2.56
4.49
3.7
3.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
233
1791
1.39
4.47
5.1
3.7
—
—
—
0
0
(4281824)
12
30
4.04
4.44
1.6
1.1
—
—
—
0
0
(3010421) pH of Blood
43
217
2.02
4.42
6.0
4.0
ph
7.4
7.4
0.46
36
174
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
141
991
1.49
4.38
1.3
1.2
u/ml
20.9
15.1
0.26
50
349
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
11
26
4.27
4.36
1.9
1.3
%
64.0
61.8
0.07
11
21
(3034770) Mitochondria Ab [Titer] in Serum
37
178
2.12
4.31
1.2
1.2
—
602.0
—
0
5
(3039000) Anion gap in Blood
39
192
2.07
4.29
6.1
5.5
mmol/l
10.9
11.2
0.20
34
176
(3018572) Chloride [Moles/volume] in Blood
39
192
2.07
4.29
6.1
5.6
mmol/l
104.7
105.5
0.40
34
176
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
6
11.73
4.28
1.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
51
277
1.89
4.26
5.6
5.2
mmol/l
1.3
1.3
0.20
46
247
(3028626) Oxygen [Partial pressure] in Capillary blood
40
200
2.04
4.22
3.9
3.3
kpa
7.5
7.8
0.45
35
184
(3051651) Icteric interference index of Serum or Plasma
13
36
3.64
4.21
4.9
2.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
28
122
2.33
4.13
1.5
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
25
104
2.44
4.08
2.3
1.6
%
87.9
89.7
0.93
25
104
(3000475) Leukocytes [#/volume] in Synovial fluid
40
203
2.01
4.07
1.7
1.6
e6/l
22094.3
15580.8
0.48
32
144
(4268621)
15
47
3.22
4.06
2.2
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
118
812
1.51
4.06
6.1
3.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
49
267
1.88
4.06
3.7
2.7
g/l
0.2
0.3
0.33
28
84
(40768793) Breast Pathology biopsy report
13
37
3.55
4.06
1.3
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
96
632
1.57
4.03
1.4
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
131
926
1.48
3.96
3.4
3.2
ng/l
294.1
277.4
0.17
115
863
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
12
33
3.67
3.93
1.1
1.1
u/l
79.8
27.0
—
6
23
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
12
33
3.67
3.93
1.1
1.1
u/l
180.8
92.8
—
6
24
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
76
2.66
3.91
1.2
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
5
12.06
3.76
2.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
26
115
2.29
3.73
1.5
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
127
903
1.46
3.73
3.0
2.6
ug/l
5.1
6.6
0.92
100
773
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
28
128
2.22
3.73
1.2
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
34
170
2.03
3.62
3.4
2.2
%
12.9
15.9
3.78
18
84
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
35
3.46
3.62
1.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
69
431
1.64
3.61
3.0
2.6
e6/l
0.4
0.3
0.18
69
421
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
172
1301
1.39
3.59
1.3
1.2
u/ml
3.0
1.5
0.54
43
335
(3021788) Differential panel - Synovial fluid
32
157
2.07
3.59
1.4
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
252
2023
1.33
3.58
5.4
4.1
estimate
0.0
0.0
0.00
80
593
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
39
206
1.93
3.58
1.8
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
39
206
1.93
3.58
1.8
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
9
7.82
3.56
1.1
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
9
7.82
3.56
1.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
14
46
3.07
3.54
1.3
1.5
ug/l
14.3
15.8
0.27
14
46
(3032057) Clostridioides difficile [Presence] in Stool
9
17
5.33
3.51
1.8
2.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
13
6.19
3.50
1.1
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
6
10.05
3.50
1.0
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
767
7121
1.31
3.43
48.6
15.1
mg/l
29.0
26.5
1.11
723
5695
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
70
2.60
3.39
1.2
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
18
5.03
3.37
3.2
2.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
14
5.75
3.34
1.4
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
99
687
1.49
3.30
2.0
1.9
ug/g
206.4
169.7
0.26
80
518
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
7
8.61
3.26
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
6
7
8.61
3.26
1.0
1.0
—
—
—
0
0
(3020891) Body temperature
58
357
1.66
3.24
5.5
4.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
38
3.18
3.22
1.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
15
5.37
3.19
1.1
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
11
6.40
3.19
1.1
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
15
55
2.75
3.16
3.8
2.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
229
0.34
3.08
1.6
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
99
2.25
3.07
1.5
1.4
%
54.7
67.4
0.61
15
65
(3036048) Francisella tularensis Ab [Titer] in Serum
6
8
7.54
3.06
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
150
1939
0.73
3.05
3.0
3.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
16
5.03
3.05
4.0
1.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
16
5.03
3.05
1.3
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
12
5.86
3.02
3.0
2.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
5
10.04
2.98
1.0
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
5
5
10.04
2.98
1.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
31
162
1.94
2.97
3.1
2.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
34
185
1.87
2.90
1.3
1.4
ug/g
234.9
299.4
0.94
18
109
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
665
7151
0.80
2.90
4.8
5.4
mmol/l
2.1
2.5
22.02
591
6437
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
23
3.94
2.78
1.1
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
6
8.37
2.75
2.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
6
8.37
2.75
1.2
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
6
8.37
2.75
2.0
1.0
%
81.8
116.8
—
5
6
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
6
8.37
2.75
2.2
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
140
1.95
2.67
1.1
1.1
—
—
—
0
0
(3013512) EKG study
286
2417
1.25
2.65
5.6
4.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
329
2825
1.24
2.64
5.4
4.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
15
61
2.48
2.62
1.5
1.4
pmol/l
143.8
69.9
0.82
15
61
(3027456) Digoxin [Moles/volume] in Serum or Plasma
42
253
1.69
2.59
2.5
3.4
nmol/l
0.8
0.8
0.11
23
200
(3010144) Erythrocytes [#/volume] in Synovial fluid
17
74
2.32
2.59
1.5
1.3
e6/l
26278.3
345215.5
1.25
12
48
(3004616) Nuclear Ab [Presence] in Serum
19
87
2.21
2.58
1.6
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
208
1.76
2.57
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
19
88
2.18
2.52
1.3
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
26
3.48
2.48
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
36
211
1.73
2.46
1.2
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
151
1888
0.76
2.41
3.3
2.8
ug/l
0.7
0.8
0.41
95
1347
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
635
6811
0.82
2.41
6.5
6.7
mmol/mol
39.8
41.3
3.18
576
6208
(42529406) Shigella sp [Presence] in Stool by Culture
36
213
1.72
2.38
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
47
299
1.60
2.37
2.4
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
22
3.66
2.36
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
16
71
2.27
2.35
4.5
3.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
72
2.24
2.28
1.1
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
25
134
1.89
2.28
1.4
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
32
189
1.72
2.15
2.7
2.0
g/l
102.3
130.5
6.49
23
139
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
19
3.70
2.15
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
19
3.70
2.15
1.1
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
30
3.02
2.15
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
30
3.02
2.15
1.1
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
42
268
1.59
2.12
2.4
1.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
25
3.22
2.09
1.1
1.1
iu/ml
99.5
135.2
—
8
25
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
25
3.22
2.09
2.3
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
78
569
1.40
2.07
6.0
2.4
ml/min/173m2
51.7
59.9
1.56
45
242
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
191
0.41
2.06
1.3
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
27
154
1.77
2.05
1.3
1.4
mmol/l
56.8
63.0
0.28
20
123
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
576
5317
1.19
2.05
3.9
3.6
pmol/l
15.0
15.1
0.36
516
4706
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
192
1.69
2.05
1.6
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
15
4.02
2.04
1.5
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
40
255
1.59
2.03
1.6
1.2
—
—
—
0
0
(1002224) Polysomnography panel
6
160
0.37
2.03
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
26
3.09
2.01
1.1
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
67
479
1.43
2.00
1.1
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
645
6860
0.84
1.99
4.4
4.7
mmol/l
1.3
1.4
10.96
569
6158
(3013005) Retinol [Moles/volume] in Serum or Plasma
5
11
4.56
1.94
1.4
4.3
umol/l
2.0
1.3
—
5
11
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
654
6940
0.84
1.93
4.4
4.8
mmol/l
3.8
4.4
29.95
584
6278
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
33
2.74
1.93
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
40
2.51
1.84
1.5
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
40
2.51
1.84
1.5
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
77
574
1.37
1.82
5.0
3.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
12
4.18
1.82
1.8
2.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
102
1.88
1.77
2.2
2.9
—
23.3
—
0
24
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
271
0.51
1.76
1.5
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
281
0.53
1.71
1.5
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
89
1.93
1.70
2.6
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
246
2810
0.84
1.68
4.5
4.0
%
22.2
24.3
1.23
108
1433
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
49
2.26
1.64
1.4
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
56
2.16
1.61
2.2
1.7
—
—
—
0
0
(4015189)
8
32
2.51
1.60
1.3
2.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
15
3.34
1.52
1.4
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
51
2.17
1.51
1.1
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
205
1770
1.20
1.50
5.4
4.2
kg/l
1.0
1.0
0.10
36
296
(3045424) Erythrocytes [Presence] in Urine
16
87
1.85
1.46
1.5
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
38
2.38
1.46
3.3
3.7
—
—
—
0
0
(4306422)
12
59
2.05
1.44
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
59
2.05
1.44
1.0
1.1
—
—
—
0
0
(3036603) Volume of Urine
9
39
2.32
1.43
1.3
1.5
—
1956.8
—
0
14
(3035285) Chloride [Moles/volume] in Venous blood
21
126
1.68
1.41
2.8
2.2
mmol/l
105.8
105.1
0.32
21
126
(3041354) Potassium [Moles/volume] in Venous blood
21
126
1.68
1.41
2.8
2.2
mmol/l
4.1
4.1
0.29
21
126
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
46
2.19
1.40
1.5
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
46
2.19
1.40
1.9
2.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
643
6088
1.15
1.40
49.9
16.6
%
32.0
38.5
33.83
361
3630
(3013139) Helicobacter pylori Ag [Presence] in Stool
58
434
1.36
1.39
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
39
272
1.45
1.39
1.3
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
296
0.60
1.34
1.6
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
629
6615
0.87
1.34
4.6
4.2
mmol/l
1.2
1.3
1.17
560
5875
(3020491) Glucose [Moles/volume] in Blood
13
68
1.92
1.33
2.0
2.7
mmol/l
7.3
7.2
—
8
43
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
34
2.36
1.29
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
20
122
1.65
1.28
2.9
2.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
48
2.09
1.28
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
48
2.09
1.28
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
48
2.09
1.28
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
55
416
1.34
1.25
2.4
2.5
—
16.4
—
0
7
(3041096) Erythrocytes [Presence] in Urine by Automated
213
1876
1.17
1.25
4.5
3.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
49
2.05
1.22
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
49
2.05
1.22
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
49
2.05
1.22
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
49
2.05
1.22
2.5
2.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
37
2.17
1.21
1.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
118
988
1.22
1.21
4.3
5.0
%
32.8
33.1
0.08
85
637
(3038515) Glucose [Moles/volume] in Venous blood
30
207
1.46
1.16
6.4
2.8
mmol/l
7.9
7.8
0.03
30
202
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
52
672
0.76
1.12
1.6
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
27
184
1.48
1.11
2.9
2.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
137
0.51
1.10
1.0
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
60
470
1.29
1.10
4.5
3.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
173
1515
1.17
1.10
3.2
2.3
mmol/l
2.4
2.4
2.00
159
1284
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
12
67
1.80
1.05
1.2
1.1
—
71.2
—
0
5
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
53
1.90
1.01
1.3
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
35
258
1.37
0.98
4.8
4.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
50
1.81
0.96
1.7
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
77
1.70
0.95
1.3
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
51
1.77
0.94
1.7
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
28
2.15
0.91
1.0
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
684
7082
0.90
0.90
5.7
5.0
mmol/l
6.1
6.1
0.55
601
6296
(3037556) Urate [Mass/volume] in Serum or Plasma
6
29
2.08
0.89
2.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
56
1.79
0.88
1.0
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
588
5625
1.11
0.87
64.2
17.8
%
16.8
13.8
72.44
583
5447
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
311
1.30
0.82
1.1
1.2
iu/ml
41.7
114.6
1.86
14
121
(3020961) Endomysium IgA Ab [Titer] in Serum
32
241
1.34
0.81
1.2
1.1
—
120.2
—
0
6
(3032773) Endomysium IgG Ab [Titer] in Serum
8
47
1.71
0.80
1.6
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
12
74
1.63
0.78
5.0
3.5
mg/l
19.1
40.3
—
7
64
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
3.2
2.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
38
1.85
0.73
1.3
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
25
2.00
0.72
1.4
1.3
—
—
—
0
0
(4024509)
10
60
1.67
0.72
1.7
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
57
1.58
0.71
1.4
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
7
41
1.71
0.70
2.0
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
27
1.86
0.68
1.8
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
66
559
1.19
0.67
3.0
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
121
1077
1.14
0.66
12.3
7.8
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
1.0
1.2
u/l
30.9
23.0
—
5
21
(4094501)
12
174
0.69
0.59
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
18
139
1.30
0.44
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
31
1.62
0.43
1.8
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
10
70
1.43
0.41
1.5
1.5
—
196.4
—
0
11
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
268
1.20
0.41
1.3
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
16
0.00
0.41
0.0
8.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
59
1.36
0.41
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
214
1.22
0.39
1.7
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
671
6577
1.06
0.37
4.9
4.5
mu/l
2.2
2.2
0.00
611
5847
(3044889) 12 lead EKG panel
506
5195
0.95
0.36
5.4
4.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
42
1.43
0.35
1.5
2.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
770
7585
1.06
0.34
45.9
18.6
mmol/l
138.9
139.7
13.35
751
7333
(3003338) MCHC [Mass/volume]
564
5765
0.95
0.33
67.3
20.1
g/l
327.7
331.8
15.39
557
5694
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
99
0.71
0.30
2.4
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
10
75
1.34
0.30
1.0
1.4
—
—
—
0
0
(4034850)
31
269
1.16
0.29
24.2
12.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
139
1.23
0.29
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
770
7600
1.05
0.29
48.2
18.8
mmol/l
4.0
4.0
1.92
753
7339
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
12
151
0.79
0.28
2.8
1.3
nmol/l
0.8
0.8
—
7
126
(3000492) Spirometry study
56
510
1.10
0.26
1.6
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
79
732
1.09
0.26
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
88
1.25
0.22
1.4
1.2
nmol/l
0.7
0.7
0.12
11
83
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
40
1.25
0.22
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
116
1.21
0.22
1.3
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
41
1.22
0.22
1.0
1.1
—
5.2
—
0
8
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
2.9
—
0.3
—
0
10
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
206.4
—
0
5
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
354
3457
1.04
0.20
4.9
4.1
ug/l
2.1
2.2
0.33
301
3057
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
117
1.20
0.20
2.6
2.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
10
80
1.25
0.20
2.3
2.3
ml
898.0
633.6
—
5
54
(3019230) Fractional oxyhemoglobin in Venous blood
16
136
1.18
0.20
2.2
2.3
%
60.4
60.8
0.02
16
136
(3011985) Renin [Units/volume] in Plasma
10
82
1.22
0.17
1.0
1.3
mu/l
114.1
59.0
—
10
72
(3011648) Oxygen content in Venous blood
7
63
1.11
0.17
1.7
2.1
%
9.3
10.3
—
7
63
(3023410) Appearance of Cerebral spinal fluid
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
662
6549
1.03
0.17
38.1
14.0
ml/min/173m2
71.2
72.0
0.35
579
5233
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
8
68
1.18
0.16
1.6
1.5
—
28.0
—
0
5
(40761511) CBC panel - Blood by Automated count
735
7285
1.03
0.16
40.8
15.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
80
1.13
0.15
1.6
1.3
—
—
—
0
0
(4010399)
50
533
0.93
0.15
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
81
1.11
0.15
1.4
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
103
1.17
0.13
1.7
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
96
0.83
0.13
1.3
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
117
0.85
0.13
1.5
2.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
776
7809
0.97
0.12
75.1
21.8
e9/l
7.2
6.9
0.23
751
7473
(3000963) Hemoglobin [Mass/volume] in Blood
776
7808
0.97
0.12
75.8
21.9
g/l
108.0
133.9
177.13
756
7602
(3026361) Erythrocytes [#/volume] in Blood
776
7807
0.97
0.11
75.1
21.8
e12/l
3.5
4.4
146.96
747
7466
(3035941) MCH [Entitic mass]
776
7807
0.97
0.11
74.7
21.7
pg
31.3
30.5
13.73
760
7603
(3007461) Platelets [#/volume] in Blood
776
7806
0.98
0.11
75.3
21.8
e9/l
190.1
237.2
20.21
749
7504
(3024731) MCV [Entitic volume]
776
7805
0.98
0.11
74.9
21.7
fl
95.5
91.7
32.87
759
7599
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
6
54
1.11
0.09
3.2
2.2
—
72.7
—
0
13
(3011288) Drugs identified in Urine by Screen method
6
58
1.03
0.08
1.3
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
63
0.79
0.08
27.8
13.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
58
559
1.04
0.08
1.5
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
67
1.05
0.08
1.1
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
260
2634
0.98
0.07
3.7
3.2
mmol/l
6.8
7.3
0.99
215
2189
(3020682) Albumin/Creatinine [Ratio] in Urine
271
2744
0.98
0.07
4.4
4.0
mg/mmol
14.0
7.9
0.69
182
1778
(3005570) Glucose [Moles/volume] in Urine
10
91
1.10
0.04
2.4
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
18
190
0.95
0.04
4.4
3.4
mg/l
41.7
27.5
0.53
11
125
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
241
1.04
0.02
2.4
2.3
ug/min
239.8
113.7
0.48
11
143
(3012516) Albumin [Mass/volume] in Urine
257
2583
0.99
0.02
3.8
3.2
mg/l
1912.9
198.8
2.07
190
1674
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
257
0.97
0.01
1.1
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
753
7521
1.00
0.01
28.3
9.1
u/l
27.0
24.1
0.43
729
7118
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
166
0.96
0.00
2.9
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
106
1.04
0.00
1.4
1.9
pmol/l
174.3
211.1
1.02
11
98
(4146454)
10
99
1.01
0.00
1.8
2.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
99
1.01
0.00
1.4
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
185
1.03
0.00
1.8
2.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
82
0.98
0.00
1.6
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
82
0.98
0.00
1.6
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
5.5
—
0
6
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
19.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
19.5
—
0
6
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
83
0.96
0.00
1.6
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
81
0.99
0.00
1.3
1.2
nmol/l
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
58
0.86
0.00
1.4
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
83
0.96
0.00
1.6
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
49
1.02
0.00
1.2
1.5
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
79
1.01
0.00
1.3
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.0
—
13.1
—
0
5
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
-0.00
0.0
1.1
—
1.8
—
0
9

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MYELODYSP_SYNDR_EXALLC – Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).